Required for US and Japanese stocks. A-shares and HK stocks work without a key.
DeepSeek R1 provides high-quality analysis at very low cost. Serper provides real-time search data for context.
Required for US and Japanese stocks. A-shares and HK stocks work without a key.
DeepSeek R1 provides high-quality analysis at very low cost. Serper provides real-time search data for context.
Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment and related products in China and internationally. It offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation and anti-aging product, and sports rehabilitation products, as well as consumables and IT products, such as vaginal electrodes, rectal electrodes, and vaginal probes. The company also provides electronic colposcopes, biofeedback stimulation devices, high-frequency electrocautery devices, ultrasonic uterine involution devices, and electro-ultrasound therapy devices; and finger joint rehabilitation assessment systems, portable hand function rehabilitation assessment systems, hand function magnetic stimulation systems, transcranial magnetic stimulation systems, biofeedback devices, and portable biofeedback devices. In addition, it provides pelvic floor muscle rehabilitation devices and power recliner. It serves clients in gynecology, obstetrics, rehabilitation, proctology, postpartum recovery centers, and urology areas. The company was founded in 2013 and is headquartered in Nanjing, China.
交易所：Shanghai Stock Exchange。行业板块：Healthcare。细分行业：Medical Devices。最新股价：¥41.18。本页提供 麦澜德 的 DCF 现金流折现估值、相对估值历史分位、多维财务评分与 AI 辅助分析。